Nulojix (belatacept): Risk of medication errors due to change in maintenance dose from 5 mg/kg to 6 mg/kg

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Nulojix
Active substance
belatacept
Therapeutic area (MeSH)
  • Graft Rejection
  • Kidney Transplantation
Procedure number
EMEA/H/C/002098/II/0079/G
Regulatory outcome
Maintenance
DHPC type
Medication error
Human ATC code
L04AA28
Dissemination date
12/09/2022

How useful was this page?

Add your rating